Johnson, D. B., & Dahlman, K. B. (2018). Class matters: Sensitivity of BRAF-mutant melanoma to MAPK inhibition. Clin Cancer Res.
Citação norma ChicagoJohnson, Douglas B., and Kimberly B. Dahlman. "Class Matters: Sensitivity of BRAF-mutant Melanoma to MAPK Inhibition." Clin Cancer Res 2018.
MLA citiranjeJohnson, Douglas B., and Kimberly B. Dahlman. "Class Matters: Sensitivity of BRAF-mutant Melanoma to MAPK Inhibition." Clin Cancer Res 2018.
Opozorilo: Ti citati niso vedno 100% točni.